Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation

NCT01456000 is registered in ClinicalTrials.gov with CardioFocus as lead sponsor.

NCT NCT01456000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01456000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Lead sponsor
CardioFocus
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2012
Completion date
January 31, 2016
Enrollment
405 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation